Nursing5336 FNP Exam 2 2024
x x x x x
2017 xACC/AHA xguidelines: xnormal xBP x- x<120 x/ x<80 x
x
2017 xACC/AHA xguidelines: xelevated xBP x- x120-129/ x<80 x
x
2017 xACC/AHA xguidelines: xstage x1 xHTN x- x130-139 x/ x80-89 x
x
2017 xACC/AHA xguidelines: xstage x2 xHTN x- x≥ x140/ x≥ x90 x
x
What xis xrecommended xfor xwhite xcoat xhypertension? x- x- xlifestyle
xmodification
x
- xannual xABPM xor
xHBPM
x
What xis xrecommended xfor xmasked xhypertension? x- x- xlifestyle
xmodification
x
- xstart xHTN
xmedication
x
What xis xrecommended xfor xelevated xBP? x- x- xlifestyle
xmodification
x
- xannual
xABPM
x
What xis xsecondary xhypertension? x- x- xdrug resistant/induced
x
xhypertension
x
- xexacerbation xof xpreviously xcontrolled
xhypertension
x
- xaccelerated/malignant
xhypertension
x
- xunprovoked xor xexcessive
xhypokalemia
x
What xare xcommon xcauses xof xsecondary xhypertension? x- x- xrenal
xdisease
x
-
xaldosteronism
x
-
xOSA
x
- xdrug xand xalcohol
xinduced
x
What xare xnon-pharmacological xinterventions xfor xhypertension? x- x- xweight
xloss x- xDASH xdiet x
- sodium xreduction x
- potassium xsupplementation x
- reduce xalcohol xconsumption x
x
2017 xACC/AHA xguidelines: xclinical xCVD xand xBP x≥ x130 x/ x≥ x80 x- xuse xBP
xlowering x
, x
meds
x
2017 xACC/AHA xguidelines: xprimary xprevention xin xadults x10 xyr xASCVD xrisk xof x≥
x10% x-
x
use xBP xlowering
xmeds
x
2017 xACC/AHA xguidelines: x10 xyr xrisk x< x10% xand xSBP x≥ x140/90 x- xuse xBP
xlowering x
x
meds
x
2017 xACC/AHA xguidelines: xnormal xBP xreassessment x- xyearly x
x
2017 xACC/AHA xguidelines: xelevated xBP xreassessment x- x3-6 xmonths x
x
2017 xACC/AHA xguidelines: xstage x1 xHTN xreassessment xand x10 xyr xASCVD x< x10%
x- x3-
x
6
xmonths
x
2017 xACC/AHA xguidelines: xstage x2 xHTN xreassessment x- xone xmonth xuntil xgoal
xBP x
x
met, xthen x3-6
xmonths
x
2017 xACC/AHA xguidelines: xstage x1 xHTN xreassessment xand x10 xyr xASCVD x>
x10% x-
x
one xmonth xuntil xBP xgoal xmet, xthen x3-6
xmonths
x
What xhypertensive xmedications xshould xnot xbe xprescribed xsimultaneously? x- x-
xACE
x
-
xARB
x
- xRenin
xInhibitor
x
2017 xACC/AHA xguidelines: xfirst xline xagents x- x- xthiazide xdiuretics x
- CCBs x
- ACE x
- ARBs x
x
2017 xACC/AHA xguidelines: xinitiation xof xdrug xtherapy xin xstage x2 xHTN x- xinitiate xdrug
xtherapy xwith x2 xfirst xline xmedications xof xdifferent xclasses xas xseparate xagents xor
xcombo xdrug x
x
2017 xACC/AHA xguidelines: xinitiation xof xdrug xtherapy xin xstage x1 xHTN x- xinitiate
xtherapy x
x
with xa xsingle
xdrug
x
2017 xACC/AHA xguidelines: xHTN xreassessment xfor xnew xor xadjusted xdrug
xregimen x-
x x x x x
2017 xACC/AHA xguidelines: xnormal xBP x- x<120 x/ x<80 x
x
2017 xACC/AHA xguidelines: xelevated xBP x- x120-129/ x<80 x
x
2017 xACC/AHA xguidelines: xstage x1 xHTN x- x130-139 x/ x80-89 x
x
2017 xACC/AHA xguidelines: xstage x2 xHTN x- x≥ x140/ x≥ x90 x
x
What xis xrecommended xfor xwhite xcoat xhypertension? x- x- xlifestyle
xmodification
x
- xannual xABPM xor
xHBPM
x
What xis xrecommended xfor xmasked xhypertension? x- x- xlifestyle
xmodification
x
- xstart xHTN
xmedication
x
What xis xrecommended xfor xelevated xBP? x- x- xlifestyle
xmodification
x
- xannual
xABPM
x
What xis xsecondary xhypertension? x- x- xdrug resistant/induced
x
xhypertension
x
- xexacerbation xof xpreviously xcontrolled
xhypertension
x
- xaccelerated/malignant
xhypertension
x
- xunprovoked xor xexcessive
xhypokalemia
x
What xare xcommon xcauses xof xsecondary xhypertension? x- x- xrenal
xdisease
x
-
xaldosteronism
x
-
xOSA
x
- xdrug xand xalcohol
xinduced
x
What xare xnon-pharmacological xinterventions xfor xhypertension? x- x- xweight
xloss x- xDASH xdiet x
- sodium xreduction x
- potassium xsupplementation x
- reduce xalcohol xconsumption x
x
2017 xACC/AHA xguidelines: xclinical xCVD xand xBP x≥ x130 x/ x≥ x80 x- xuse xBP
xlowering x
, x
meds
x
2017 xACC/AHA xguidelines: xprimary xprevention xin xadults x10 xyr xASCVD xrisk xof x≥
x10% x-
x
use xBP xlowering
xmeds
x
2017 xACC/AHA xguidelines: x10 xyr xrisk x< x10% xand xSBP x≥ x140/90 x- xuse xBP
xlowering x
x
meds
x
2017 xACC/AHA xguidelines: xnormal xBP xreassessment x- xyearly x
x
2017 xACC/AHA xguidelines: xelevated xBP xreassessment x- x3-6 xmonths x
x
2017 xACC/AHA xguidelines: xstage x1 xHTN xreassessment xand x10 xyr xASCVD x< x10%
x- x3-
x
6
xmonths
x
2017 xACC/AHA xguidelines: xstage x2 xHTN xreassessment x- xone xmonth xuntil xgoal
xBP x
x
met, xthen x3-6
xmonths
x
2017 xACC/AHA xguidelines: xstage x1 xHTN xreassessment xand x10 xyr xASCVD x>
x10% x-
x
one xmonth xuntil xBP xgoal xmet, xthen x3-6
xmonths
x
What xhypertensive xmedications xshould xnot xbe xprescribed xsimultaneously? x- x-
xACE
x
-
xARB
x
- xRenin
xInhibitor
x
2017 xACC/AHA xguidelines: xfirst xline xagents x- x- xthiazide xdiuretics x
- CCBs x
- ACE x
- ARBs x
x
2017 xACC/AHA xguidelines: xinitiation xof xdrug xtherapy xin xstage x2 xHTN x- xinitiate xdrug
xtherapy xwith x2 xfirst xline xmedications xof xdifferent xclasses xas xseparate xagents xor
xcombo xdrug x
x
2017 xACC/AHA xguidelines: xinitiation xof xdrug xtherapy xin xstage x1 xHTN x- xinitiate
xtherapy x
x
with xa xsingle
xdrug
x
2017 xACC/AHA xguidelines: xHTN xreassessment xfor xnew xor xadjusted xdrug
xregimen x-
